Erectile dysfunction in male patients with fatty liver disease

Not Applicable

• Conditions: on Alcoholic Steatohepatitis; Erectile dysfunction; Metabolic Syndrome; Non Alcoholic Steatohepatitis; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Renal and Urogenital - Other renal and urogenital disorders; Metabolic and Endocrine - Metabolic disorders

• Registration Number: ACTRN12612001217897
• Lead Sponsor: Marmara University Faculty of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-11-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Male
• Target Recruitment: 50

Inclusion Criteria

Male patients with Nonalcoholic steatohepatitis.

Exclusion Criteria

Female patients
Patients who have overt diabetes that use oral antidiabetic agents or insulin
Patients using antihyperlipidemic agents, antihypertensives, testesteron derivatives
Chronic liver disease due to the causes other than Nonalcoholic steatohepatitis, such as chronic hepatitis B, C, alcohol, hemachromatosis, Wilson's disease
Diagnosed malignant disease

Study & Design

• Study Type: Observational
• Study Design: Not specified